Risk of Mortality and Heart Failure Exacerbations Associated With Inhaled β-Adrenoceptor Agonists Among Patients With Known Left Ventricular Systolic Dysfunction
- 30 June 2003
- Vol. 123 (6) , 1964-1969
- https://doi.org/10.1378/chest.123.6.1964
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Beta-adrenoceptors in cardiac diseasePublished by Elsevier ,2002
- The background of the MERIT-HF trialBasic Research in Cardiology, 2000
- Effects of Controlled-Release Metoprolol on Total Mortality, Hospitalizations, and Well-being in Patients With Heart FailureJAMA, 2000
- β-Adrenergic Receptor Blockade in Chronic Heart FailureCirculation, 2000
- Myocardial β-adrenoceptor down-regulation by norepinephrine is linked to reduced norepinephrine uptake activityEuropean Journal of Pharmacology, 1999
- Second- and third-generation beta-blocking drugs in chronic heart failure.Cardiovascular Drugs and Therapy, 1997
- Medical Therapy Can Improve the Biological Properties of the Chronically Failing HeartCirculation, 1996
- Effect of metoprolol on myocardial function and energetics in patients with nonischemic dilated cardiomyopathy: A randomized, double-blind, placebo-controlled studyJournal of the American College of Cardiology, 1994
- Receptor function in heart failureThe American Journal of Medicine, 1991
- Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human HeartsNew England Journal of Medicine, 1982